Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein by unknown
PRIMARY STRUCTURE OF LYMPHOCYTE
FUNCTION-ASSOCIATED ANTIGEN 3 (LFA-3)
The Ligand of the T Lymphocyte CD2 Glycoprotein
BY BARBARA P. WALLNER,* ALEXIS Z . FREY,* RICHARD TIZARD,*
ROBERT J . MATTALIANO,* CATHERINE HESSION,*
MARTIN E . SANDERS,1 MICHAEL L . DUSTIN,* AND
TIMOTHY A. SPRINGER*
From the *Biogen Research Corporation, Cambridge, Massachusetts02142;*The Laboratory of
Membrane Immunochemistry, Dana Farber Cancer Institute and Harvard Medical School,
Boston, Massachusetts 02115; and the §National Institutes ofHealth, National Cancer
Institute, Immunology Branch, Bethesda, Maryland 20892
The organization of specialized cells within tissues during embryogenesis and
development, as well as in inflammation, is thought to be due to a collection of
cell surface receptors that interact with molecules in the extracellular matrix and
on the surface of other cells, thereby imparting positional information . Recently,
we found (1) that lymphocyte function-associated antigen 3 (LFA-3),' a surface
glycoprotein expressed on many cell types, binds to the T lymphocyte surface
glycoprotein CD2 with a high affinity (10'-108/M) . This interaction is important
in mediating thymocyte interactions with thymic epithelial cells, antigen-inde-
pendent and -dependent interactions of T lymphocytes with target cells and
antigen-presenting cells, and the T lymphocyte rosetting with erythrocytes (1-
7) . In addition to mediating cell adhesion, it has been suggested that the LFA-
3/CD2 interaction may prime responses by both the CD2+ and LFA-3+ cells (8-
10). Although receptors for extracellular matrix components (11), and receptors
that appear to engage in like-like interactions (N-CAM) (12), have been defined,
to our knowledge CD2 and LFA-3 are the first example in which an integral
membrane protein on one cell binds to a distinct integral membrane protein on
another cell . These molecules thus represent an ideal model system for studying
cell-cell adhesion . To understand the structural basis for cognate interactions
between cell adhesion molecules, we have cloned an LFA-3 cDNA and deter-
mined the primary structure of the LFA-3 protein .
Materials and Methods
LFA-3 Purification and Sequencing.
￿
LFA-3 was purified by immunoaffinity chromatog-
raphy from human erythrocytes as described (6) . LFA-3 purified by one cycle of affinity
chromatography was deglycosylated using peptide:N-glycosidase F (N-glycanase) accord-
ing to the supplier's instructions (Genzyme, Boston, MA). The glycosylated and deglyco-
sylated forms were further purified by preparative SDS-PAGE and electroeluted exactly
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as described(13) . Deglycosylated LFA-3 was digested with trypsinand the tryptic peptides
were separated by HPLC (14) . Intact LFA-3 (300 pmol), N-glycanase-treated LFA-3 (50
pmol), and tryptic fragments (5-50 pmol) were subjected to automated Edman degrada-
tion on a gas-phase sequencer (model 470A ; Applied Biosystems, Inc., Foster City, CA)
in the presence of polybrene (15) . PTH-amino acids were identified on-line using aPTH
analyzer (model 120A ; Applied Biosystems, Inc.) .
Construction of the PBL cDNA Library.
￿
PBL from leukapheresis were stimulated with
100 U/ml IFN-y and 10 ag/ml PHA for 24 h . RNA was prepared by phenol extraction
(16), and double-stranded cDNA was synthesized from poly(A)-selected RNA by the
methodsofOkayamaand Berg (17) andGubler and Hoffman (18) . ThecDNA was ligated
to an Eco RI/blunt-ended linker, designed to allow the cDNA insert to be excised by Not
1 . Size-selected (800 by and longer) cDNA was ligated to Eco RI-digested Xgt10 arms,
and aliquots of the ligation mixture were packaged in Gigapak (Stratagene, San Diego,
CA). The packaged phage was used to infect Escherichia coli. The resulting library
contained 1 .1 X 10 6 independent recombinant phages .
Isolation ofthe cDNA Clones.
￿
106 recombinants of either the human PBL Agt10cDNA
library or a human tonsil agt11 cDNA library (a generous gift of Lloyd Klickstein,
Harvard Medical School, Boston, MA) (19) were screened with "P-labeled oligonucleotide
probes as described(20) . Antisense oligonucleotideprobes were synthesizedon an Applied
Biosystems, Inc., 30A DNA Synthesizer . Oligonucleotide probe pool LF1 wasa 20 mer,
32-fold degenerate, corresponding to amino acids 28-34 of the NH2-terminal sequence
ofLFA-3 (Table I) . Probe pools LF2 to LF5 were synthesized to residues 3-7 o£ theNH2-
terminus and were a set of four subpools, each 20 by long and 96-fold degenerate. The
nucleotide sequence of each subpool was identical except for the nucleotide in the third
position of the codon for glycine . Probes were 5' endlabeled using 'Y-[s2P)ATP (7,000
Ci/mmol ; New England Nuclear, Boston, MA or ICN Pharmaceuticals, Inc., Irvine, CA)
and polynucleotide kinase according to the protocol ofMaxam and Gilbert (21) .
DNA Sequencing.
￿
DNA sequences were determined by the method of Maxam and
Gilbert (21) and in some cases by the related procedure of Church and Gilbert (22) .
Northern Blot Analysis.
￿
A431, CEM, THP1, U937, HL60,Jurkat, HT1080 cell lines
were obtained from the American Type Culture Collection, Rockville, MD . L428 and
U266 cell lines were a gift of Steve Shaw, NIH, Bethesda, MD (23, 24), and theROHA-
9 cell line was obtained from A. Muchmore, NIH (25) . RNA from human tissues and
from 10' cells of all cell lines was prepared by the guanidinium thiocyanate-CsCl method
(26) . Poly(A)RNA was selected by passage over an oligo(dT)-cellulose column . Aliquots
of 10 Aig of total RNA or 3 ug of poly(A) RNA were electrophoresed on a 1% agarose-
formaldehyde gel, transferred to a GeneScreen membrane (New England Nuclear) and
hybridized to the respective 12P-labeled probe, essentially as described (27).
Genomic Southern Blot Analysis.
￿
DNA was extracted from the human lymphoblastoid
cell lineGMI416,48,XXXX, obtained from the Human Mutant Cell Repository, Camden,
NJ, as previously described (28) . Digestion of 20-wg aliquots of DNA with restriction
endonucleases Eco RI, Bam HI, Pvu II, or Pst I, separation of the digested DNA on an
agarose gel, transfer to nylon membrane, and hybridization to "P-labeled cDNA, were
performed essentially as described (29).
Results and Discussion
LFA-3 waspurifiedfrom human erythrocytes bymAbaffinity chromatography
(6) . In SDS-PAGE it migrated as a diffuse band of45-66,000 M, (lane 1 in Fig.
1, A-C), as previously reported (6). One batch of LFA-3 was subjected to a
second affinity chromatography step to remove minorcontaminants. No contam-
inants were detectable by SDS-PAGE, in 10% (Fig . 1A) or 15% gels (not shown) .
This batch of LFA-3 was directly subjected to gas-phase microsequencing . The
NH2-terminal 38 amino acid residues, except for one unidentifiable residue at
position 12, were determined (Table I) . A second batch of LFA-3 purified by
one cycle of affinity chromatography was divided into two aliquots, and N-linkedPeptide
NHy-Terminus, intact
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TABLE I
Sequence Data for Human LFA-3 Peptides
LFA-3 Protein Sequence
NHq-Terminus, deglyco- XSQQIYGVVYGDVTFHVPSNVPL
sylated
Tryptic peptides : T72-73
￿
DK V AE L EN S E F
*
T91 VLYDTVSGSLTIYDLTS
T105 FFLYVLESLPSPTLXXAL
T68
￿
G L I MY S
925
FIGURE 1 .
￿
Purified LFA-3 . (A) LFA-3
(150 ng) purified by two cycles ofaffinity
chromatography and run on a SDS 10%
PAGE under nonreducing conditions .
(B) LFA-3 (600 ng) purified by one cycle
of affinity chromatography (lane 1) and
the same material treated with N-glycan-
ase (lane 2). SDS 12% PAGE under re-
ducing conditions. (C) Same LFA-3 as in
B (150 ng) after electroelution from SDS
12% preparativePAGE and run on SDS
12% PAGE under reducing conditions .
All samples were visualized by silver
staining .
F SQQ IYGVVYGXVTFHVPSNV PLKEVLWKKQKDKVAEL
s
Intact, deglycosylated LFA-3 or tryptic fragments were subjected to NHQ-terminal protein sequence
analysis . Tryptic peptide designations correspond to peaks off the HPLC . Amino acid sequences
corresponding to oligonucleotide probes are underlined . N-glycosylated residues are indicated by
asterisks .
carbohydrate was removed from one aliquot with N-glycanase . The glycosylated
and deglycosylated forms (Fig . 1B, lanes 1 and 2) were purified by preparative
SDS-PAGE and electroelution (Fig . 1 C, lanes 1 and 2) . Deglycosylated LFA-3
ran as a relatively sharp band at 25,600 M,, but still retained some heterogeneity
in M,. (Fig . 1 B, lane 2; Fig. 1 C, lane 2) . The NH2-terminal sequence of the
glycosylated, SDS-PAGE-purified protein was in complete agreement with that
for the LFA-3 purified by two cycles of affinity chromatography . The only
difference in the sequence of deglycosylated LFA-3 (Table 1) was an aspartic926
￿
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CGACGAGCCATGGTTGCTGGGAGCGACGCGGGGCGGGCCCTGGGGGTCCTCAGCGTGGTCTGCCTGCTGCACTGCTTTGGTTTCATCAGCTGTt'TTTCCC 100
M V A G S D A G R A L G V L 5 V V C L L H C F G F I S C F S Q 3
-28
￿
-1 " 1
AACAAATATATGGTGTTGTGTATGGGAATGTAACTTTCCATGTACCAAGCAATGTGCCTTTAAAAGAGGTCCTATGGAAAAAACAAAAGGATAAAGTTGC 200
0 I V G V V V G N V T F H V P S N V P L K E V L W K K Q K D K V A 36
N-Terminus
AGAACTGGAAAATTCTGAATTCAGAGCTTTCTCATCTTTTAAAAATAGGGTTTATTTAGACACTGTGTCAGGTAGCCTCACTATCTACAACTTAACATCA 300
E L E N S E F R A F S S F K N R V Y L D T V S G S L__ . T I V N L T S
￿
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￿
T91
TCAGATGAAGATGAGTATGAAATGGAATCGCCAAATATTACTGATACCATGAAGTTCTTTCTTTATGTGCTTGAGTCTCTTCCATCTCCCACACTAACTT 400
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GTGCATTGACTAATGGAAGCATTGAAGTCCAATGCATGATACCAGAGCATTACAACAGCCATCGAGGACTTATAATGTACTCATGGGATTGTCCTATGGA 500
A L T N G S I E V Q C M I P E H V N S H R G L I M V S W D C P M E 136 A
￿
T68
GCAATGTAAACGTAACTCAACCAGTATATATTTTAAGATGGAAAATGATCTTCCACAAAAAATACAGTGTACTCTTAGCAATCCATTATTTAATACAACA 600
Q C K R
A
S T S I V F K M E N D L P Q K I Q C T L S N P L F A T T
￿
169
TCATCAATCATTTTGACAACCTGTATCCCAAGCAGCGGTCATTCAAGACACAGATATGCACTTATACCCATACCATTAGCAGTAATTACAACATGTATTG 700
S S I I L T T C P S S G H S R H R V A L I P I P L A V I T T C I V 203
TGCTGTATATGAATGGTATTCTGAAATGTGACAGAAAACCAGACAGAACCAACTCCAATTGATTGGTAACAGAAGATGAAGACAACAGCATAACTAAATT 800
L V M N G I L K C D R K P D R T N 5 N
￿
222
ATTTTAAAAACTAAAAAGCCATCTGATTTCTCATTTGAGTATTACAATTTTTGAACAACTGTTGGAAATGTAACTTGAAGCAGCTGCTTTAAGAAGAAAT 900
ACCCACTAACAAAGAACAAGCATTAGTTTTGGCTGTCATCAACTTATTATATGACTAGGTGCTTGCTTTTTTTGTCAGTAAATTGTTTTTACTGATGATG 1000
TAGATACTTTTGTAAATAAATGTAAATATGTACACAAGTG(AAAAAAAAAA) 1040
FIGURE 2 .
￿
DNA sequence and deduced amino acid sequence of human LFA-3 cDNA . The
signal sequence is indicated by the numbers-1 to -28 . The amino acids of the mature LFA-
3 arenumbered starting with +1 andcontinued at theend ofeach line . Nucleotide numbering
is given at the endof each line . Amino acid sequences that correspond to the sequences of the
tryptic peptides are underlined with solid lines . Potential N-glycosylation sites are indicated by
an arrow . The potential transmembrane domain is underlined with a broken line, and the
poly(A) addition signal is indicated by a line above the sequence . These sequence data have
been submitted to theEMBL/GenBank Data Librariesunder accession number Y00636 .
acid instead ofa blank at position 12, suggesting an N-glycosylated asparagine at
this residue, which was cleaved by N-glycanase to aspartic acid . We also deter-
mined the sequence of four tryptic peptides from deglycosylated LFA-3, which
were purified by HPLC (Table I) .
A series of antisense oligonucleotide probes were chemically synthesized based
on the NH2-terminal amino acid sequence of LFA-3 (Table I, underlined) .
Because of the high degeneracy of one probe pool, it was synthesized in four
subpools (LF2 to LF5) . The subpool containing the correct LFA-3 sequence was
determined by hybridization of each individual subpool to human tonsil RNA in
a Northern blot analysis, as described previously (27) . One subpool (LF2)
hybridized to the same-sized mRNA (1 .3 kb) as did the independent oligonucle-
otide pool LF1, which suggested that these 2 oligonucleotide pools contained
the correct sequence for LFA-3 .
The two probe pools were used to screen two cDNA libraries : a size-selected
human tonsil XgtI I cDNA library (19) and a agt10cDNA library prepared from
human PBL . Initially, 26 positive phage were isolated from thePBL library and
12 positive phage from the tonsil library . Two independent isolates from each
library were subcloned and their DNA sequences were determined (Fig . 2) .
Correspondence between the deduced amino acid sequence and LFA-3 NH2-
terminal and tryptic peptide sequences (underlined in Fig . 2) confirmed the
identity of the clones .
The 1,040-by-long sequence ofLFA-3cDNA contains a 5' untranslated region
of 9 bp, followed by an open reading frame of 750 by (Fig . 2) . The 281-bp 3'WALLNER ET AL .
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untranslated region contains a consensus polyadenylation signal (Fig . 2, over-
lined) . The first ATG located at 84 by upstream of the NH2-terminus of the
mature LFA-3 glycoprotein is the probable translational initiation site . This
indicates that LFA-3 is synthesized as a 250-amino-acid preprotein containing a
hydrophobic signal sequence of 28 residues . The mature protein of 222 amino
acids is 24,400 M,, which is in close agreement with theMT determined by SDS-
PAGE of the deglycosylated polypeptide chain of 25,500 M,. (Fig . 1) or 29,000
M,. (see below) .
ThecDNA sequence defines a typical membrane bound protein with an NH2-
terminal domain of average hydrophobicity, followed by a highly hydrophobic
transmembrane region and a COOH-terminal hydrophilic domain . The NH2-
terminal domain of 188 amino acids contains all six potential N-glycosylation
sites (Asn-Xaa-Ser/Thr) (Fig . 2) . Sequencing of glycosylated and deglycosylated
LFA-3 showed that this domain is glycosylated and hence is extracellular .
Cleavage by N-glycanase ofN-linked carbohydrates occurs within the amide bond
of the asparaginyl moiety, converting the N-glycosylated asparagine residue to
an aspartic acid residue. NH 2-terminal sequencing showed N-glycanaseconverted
position 12 of LFA-3 from a blank (glycosylated asparagines are not identified)
to an aspartic acid and the cDNA sequence shows asparagine at this residue .
Thus, the LFA-3 protein is N-glycosylated at this position . Similarly, the cDNA
predicts an asparagine in a potential N-glycosylation site at position 66, while the
deglycosylated tryptic peptide T91 shows aspartic acid at this position (Table I,
asterisk), indicating that this potential N-glycosylation site is also used .
Pulse-chase labeling of diverse LFA-3+ cell types (Dustin, M. L., andT. A.
Springer, unpublished observations) with [35S]-methionine has revealed, in all
cell lines thus far tested, two LFA-3 precursors of M, 43,000 and 41,000 Mr .
Digestion of these precursors, in which the carbohydrate moieties are in the high
mannose form, with N-glycanase or EndoH reduces their apparent M,. to 29,000
and 25,500, respectively . This indicates a contribution of 14-15,000 M, by high
mannosecarbohydrates . An estimate of 2,500Mrperhigh mannose carbohydrate
(30) predicts six N-linked carbohydrates, suggesting that all ofthe other potential
N-glycosylation sites are used . The mature LFA-3 glycoprotein is heterogeneous
in Mr on individual cell types and varies from 43,000 to 76,000 M, depending
on cell type (Dustin and Springer, unpublished observations) . The polypeptide
chain of M, 24,400 defined by the cDNA sequence shows that the mature
glycoprotein is 44-68% carbohydrate .
The predicted transmembrane domain consists of 23 uncharged amino acids,
most of which are hydrophobic in character . The putative cytoplasmic domain
is short, consisting of 12 hydrophilic residues . While this work was in progress
we found, corresponding to the two LFA-3 precursors, two forms of mature
LFA-3 that differ in membrane attachment as distinguished by their sensitivity
to phosphatidylinositol-specific phospholipase C (PIPLC) (31 ; Dustin, M. L., et
al ., manuscript in preparation) . The high molecular weight precursor remains
membrane bound, while the lower molecular weight form is released upon
PIPLC treatment, indicating membrane attachment through a PI-glycolipid
membrane anchor (32) . This suggests that the structural difference between
these two proteins resides in the COON-termini .
Phosphatidylinositol-glycan moiety is attached to the extracellular domain of928
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membrane proteins by a transamidation reaction in which a COOH-terminal
hydrophobic sequence in the protein is displaced (32) . We have determined that
the human genome contains a single LFA-3 gene (see below), suggesting gener-
ation of two forms at the protein or mRNA levels . Although most PI-anchored
proteins have hydrophobic transmembrane precursor sequences with no or
insignificant cytoplasmic domains, the "signal" for PI attachment remains unde-
fined (32) . It is thus possible that this LFA-3 sequence we have defined is
expressed as the membrane-integrated form with the transmembrane domain
intact and that it may also act as a precursor for PI attachment. This would
generate both forms from a single protein and mRNA precursor . Since PI is
added extremely rapidly (32), this is consistent with the detection oftwo protein
precursors at the earliest time points . Alternatively, differential mRNA splicing
could generate two distinct transmembrane domains, only one of which is
exchanged for the PI anchor, as has been demonstrated recently for N-CAM
(reviewed in reference 32) .
We therefore examined a number of LFA-3 cDNA clones for differences in
their 3' sequences by Southern blot analysis, and determined the complete DNA
sequence of four independent isolates . All clones examined so far had identical
3' regions . More extensive investigation is required to determine whether the
two forms of LFA-3 are coded for by a single or two distinct mRNAs .
LFA-3 is a cell surface molecule with a broad tissue distribution . It has been
found in most tissues examined, including most blood cells, epithelial, and
endothelial cells. It was of interest to determine the presence and size of LFA-3
transcripts in various tissues and cell lines . The LFA-3 cDNA hybridizes to an
~1 .3-kb transcript in RNA extracted from human tonsil, kidney, placenta, and
skin . LFA-3 transcripts are also present in HT1080 cells (a human fibrosarcoma
cell line), A431 (a human carcinoma cell line), CEM (human acute lymphoblastic
leukemia), THP1 (human monocyte leukemia), U937 (human histiocytic lym-
phoma, U266 (plasmacytoma, B lineage), JY (B lymphoblastoid), L428 (Reid-
Sternberg, Hodgkin's), ROHA9 (human Burkitt lymphoma), K562 (erythroleu-
kemia), and Jurkat (T lymphoma) . No LFA-3 mRNA could be detected in this
subline ofHL60 cells (a promyelocytic leukemia cell line) (Fig . 3) .
A Southern blot analysis on human genomic DNA indicated that LFA-3 is
coded for by a single gene in the human genome . The 220-bp fragment from
the 5' end of the LFA-3 cDNA insert was used as a hybridization probe . This
probe contains an internal Pvu II site, and hybridizes to only two fragments of
the Pvu 11-digested human DNA (Fig . 4), and to only one fragment of the Pst I
digest, which indicates a single gene for human LFA-3 . The two hybridizing
bands of equal intensity in the Bam HI digest and the two bands of unequal
intensity in the Eco RI digest predict that the 220-bp probe sequence is inter-
rupted by an intron in the LFA-3 gene .
No significant homologies with LFA-3 were detected by a FASTP search of
the National Biomedical Research Foundation Protein (release 12 .0) and NEW
(release 27.0) databases (33) . CD2, the receptor for LFA-3, has recently been
cloned in the human and rat (34-37) . Homology of short CD2 segments with
the Ig superfamily has been reported by some groups (34, 35, 37) . It has been
proposed that cell-cell adhesion may be mediated by interactions between Ig-WALLNER ET AL . 929
FIGURE 3 . Northern
￿
blot
analysis . RNA from indicated
cell sources was separated on
1% formaldehyde-agarose gel
and probed with ' P-labeled
LFA-3 cDNA. (A and C) 3 wg
poly(A) RNA from HT1080
and ROHA-9 cells and 10 ug
total RNA from all other cell
lines was applied . (B) Human
tonsil, kidney,and placenta : 3
ag poly(A) RNA;human skin:
10 ug total RNA. To assure
equal loading ofRNA in each
sample, each Northern blot
was also hybridized to 12P-la-
beled bovine pyruvate kinase
cDNA (shown for panel A
only) .
FIGURE 4.
￿
Southern blot analysis. Aliquots of 20 ug human
genomic DNA was digested with the indicated restriction
endonucleases, separatedon 1% agarose gel, transferred to
a nylon membrane and hybridized to "P-labeled 220-bp 5'
fragment of LFA-3 cDNA .930
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like domains (38) . Secondary structure predictions for LFA-3 show ,S strands
containing cysteines that might assume an Ig-like structure .
As mentioned above, CD2 and LFA-3 are the first reported example of two
distinct integral membrane glycoproteins that interact with one another to
mediate cell adhesion . The isolated cDNA clones will facilitate study of the
structural features of LFA-3 and CD2 that are important in this interaction, as
well as in signal transduction .
Summary
We have isolated the cDNA forhumanlymphocyte function-associated antigen
3 (LFA-3), the ligand of the T lymphocyte CD2 molecule . The identity of the
clones was established by comparison of the deduced amino acid sequence to the
LFA-3 NH2-terminal and tryptic peptide sequences . The cDNA defines a mature
protein of 222 amino acids that structurally resembles typical membrane-an-
chored proteins . An extracellular domain with six N-linked glycosylation sites is
followed by a hydrophobic putative transmembrane region and a short cyto-
plasmic domain . The mature glycoprotein is estimated to be 44-68% carbohy-
drate .
Southern blots ofhuman genomic DNA indicate that only one gene codes for
human LFA-3 . Northern blot analysis demonstrates that the LFA-3 mRNA of
1 .3 kb is widely distributed in human tissues and cell lines .
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